These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30565132)

  • 1. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
    Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
    BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat stress activates YAP/TAZ to induce the heat shock transcriptome.
    Luo M; Meng Z; Moroishi T; Lin KC; Shen G; Mo F; Shao B; Wei X; Zhang P; Wei Y; Guan KL
    Nat Cell Biol; 2020 Dec; 22(12):1447-1459. PubMed ID: 33199845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling.
    Hillmer RE; Link BA
    Cells; 2019 May; 8(5):. PubMed ID: 31137701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
    Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
    Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Mediated Approaches to Regulate YAP/TAZ Levels.
    Quinton RJ; Ganem NJ
    Methods Mol Biol; 2019; 1893():203-214. PubMed ID: 30565136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression.
    Ning B; Tilston-Lunel AM; Simonetti J; Hicks-Berthet J; Matschulat A; Pfefferkorn R; Spira A; Edwards M; Mazzilli S; Lenburg ME; Beane JE; Varelas X
    J Exp Clin Cancer Res; 2023 May; 42(1):116. PubMed ID: 37150829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function.
    Watt KI; Goodman CA; Hornberger TA; Gregorevic P
    Exerc Sport Sci Rev; 2018 Apr; 46(2):92-96. PubMed ID: 29346163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.
    Zanconato F; Forcato M; Battilana G; Azzolin L; Quaranta E; Bodega B; Rosato A; Bicciato S; Cordenonsi M; Piccolo S
    Nat Cell Biol; 2015 Sep; 17(9):1218-27. PubMed ID: 26258633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.
    Yu FX; Zhao B; Panupinthu N; Jewell JL; Lian I; Wang LH; Zhao J; Yuan H; Tumaneng K; Li H; Fu XD; Mills GB; Guan KL
    Cell; 2012 Aug; 150(4):780-91. PubMed ID: 22863277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
    Gershoni A; Hassin O; Nataraj NB; Baruch S; Avioz-Seligman A; Pirona AC; Fellus-Alyagor L; Meir Salame T; Mukherjee S; Mallel G; Yarden Y; Aylon Y; Oren M
    Mol Oncol; 2023 Dec; 17(12):2675-2693. PubMed ID: 37716913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AR activates YAP/TAZ differentially in prostate cancer.
    Salem O; Jia S; Qian BZ; Hansen CG
    Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37385752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression.
    Lu Y; Wu T; Gutman O; Lu H; Zhou Q; Henis YI; Luo K
    Nat Cell Biol; 2020 Apr; 22(4):453-464. PubMed ID: 32203417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.
    Hagenbeek TJ; Zbieg JR; Hafner M; Mroue R; Lacap JA; Sodir NM; Noland CL; Afghani S; Kishore A; Bhat KP; Yao X; Schmidt S; Clausen S; Steffek M; Lee W; Beroza P; Martin S; Lin E; Fong R; Di Lello P; Kubala MH; Yang MN; Lau JT; Chan E; Arrazate A; An L; Levy E; Lorenzo MN; Lee HJ; Pham TH; Modrusan Z; Zang R; Chen YC; Kabza M; Ahmed M; Li J; Chang MT; Maddalo D; Evangelista M; Ye X; Crawford JJ; Dey A
    Nat Cancer; 2023 Jun; 4(6):812-828. PubMed ID: 37277530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Hippo pathway signaling and A-kinase anchoring protein 13 in primordial follicle activation and inhibition.
    Maher JY; Islam MS; Yin O; Brennan J; Gough E; Driggers P; Segars J
    F S Sci; 2022 May; 3(2):118-129. PubMed ID: 35560009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications.
    Sun T; Chi JT
    Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development.
    Kim G; Bhattarai PY; Lim SC; Lee KY; Choi HS
    Cell Oncol (Dordr); 2024 Jun; 47(3):967-985. PubMed ID: 38112979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma.
    Papavassiliou KA; Sofianidi AA; Papavassiliou AG
    J Cell Mol Med; 2024 Apr; 28(8):e18330. PubMed ID: 38606782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of stem cell renewal and fate by YAP and TAZ.
    Driskill JH; Pan D
    Nat Rev Mol Cell Biol; 2023 Dec; 24(12):895-911. PubMed ID: 37626124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.